These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Mutations and/or Overexpressions of ERG4 and ERG11 Genes in Clinical Azoles-Resistant Isolates of Candida albicans. Feng W, Yang J, Xi Z, Qiao Z, Lv Y, Wang Y, Ma Y, Wang Y, Cen W. Microb Drug Resist; 2017 Jul; 23(5):563-570. PubMed ID: 27976986 [Abstract] [Full Text] [Related]
23. Prevalence of Candida dubliniensis among cancer patients in Kuwait: a 5-year retrospective study. Mokaddas E, Khan ZU, Ahmad S. Mycoses; 2011 Jul; 54(4):e29-34. PubMed ID: 20002881 [Abstract] [Full Text] [Related]
24. Candida dubliniensis: an appraisal of its clinical significance as a bloodstream pathogen. Khan Z, Ahmad S, Joseph L, Chandy R. PLoS One; 2012 Jul; 7(3):e32952. PubMed ID: 22396802 [Abstract] [Full Text] [Related]
25. Multilocus sequence typing indicates diverse origins of invasive Candida tropicalis isolates in China. Fan X, Xiao M, Wang H, Zhang L, Kong F, Lu J, Hu Z, Kang M, Xu Y. Chin Med J (Engl); 2014 Jul; 127(24):4226-34. PubMed ID: 25533826 [Abstract] [Full Text] [Related]
27. Epidemiology and Molecular Basis of Resistance to Fluconazole Among Clinical Candida parapsilosis Isolates in Kuwait. Asadzadeh M, Ahmad S, Al-Sweih N, Khan Z. Microb Drug Resist; 2017 Dec; 23(8):966-972. PubMed ID: 28353392 [Abstract] [Full Text] [Related]
34. Increasing prevalence, molecular characterization and antifungal drug susceptibility of serial Candida auris isolates in Kuwait. Khan Z, Ahmad S, Al-Sweih N, Joseph L, Alfouzan W, Asadzadeh M. PLoS One; 2018 Dec; 13(4):e0195743. PubMed ID: 29630658 [Abstract] [Full Text] [Related]
35. National surveillance of antifungal susceptibility of Candida species in South Korean hospitals. Yoo JI, Choi CW, Lee KM, Kim YK, Kim TU, Kim EC, Joo SI, Yun SH, Lee YS, Kim BS. Med Mycol; 2009 Dec; 47(5):554-8. PubMed ID: 18819023 [Abstract] [Full Text] [Related]
37. In vitro antifungal susceptibility of clinical isolates of Candida spp. obtained from patients with different predisposing factors to candidosis. Pinto PM, Weikert-Oliveira Rde C, Lyon JP, Cury VF, Arantes RR, Koga-Ito CY, Resende MA. Microbiol Res; 2008 Dec; 163(5):579-85. PubMed ID: 16962755 [Abstract] [Full Text] [Related]
38. In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents. Pfaller MA, Diekema DJ, Messer SA, Boyken L, Hollis RJ, Jones RN. Diagn Microbiol Infect Dis; 2004 Feb; 48(2):101-5. PubMed ID: 14972378 [Abstract] [Full Text] [Related]
39. Candida dubliniensis identification in Brazilian yeast stock collection. Mariano Pde L, Milan EP, da Matta DA, Colombo AL. Mem Inst Oswaldo Cruz; 2003 Jun; 98(4):533-8. PubMed ID: 12937769 [Abstract] [Full Text] [Related]
40. In vitro activities of new and conventional antimycotics against fluconazole-susceptible and non-susceptible Brazilian Candida spp. isolates. Alves SH, Da Matta DA, Azevedo AC, Loreto ES, Boff E, Santurio JM, Guarro J. Mycoses; 2006 May; 49(3):220-5. PubMed ID: 16681814 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]